Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EFX Sports is a prominent sports nutrition and dietary supplement company that focuses on the research, development, and manufacturing of performance-based products. The company is widely recognized for its flagship product, Kre-Alkalyn, a patented pH-buffered creatine monohydrate designed to improve stability and absorption compared to traditional creatine. As a brand under All American Pharmaceutical, EFX Sports benefits from vertically integrated manufacturing and in-house testing facilities that adhere to Good Manufacturing Practices (GMP). Their product line encompasses a variety of categories, including pre-workouts, amino acids, and protein supplements, all formulated with a focus on purity and athletic efficacy. The company maintains a strong commitment to drug-free sport, frequently utilizing third-party certifications to verify the absence of banned substances.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EFX Sports.